the greater content ofglycosaminoglycans appears to be related to increased synthesis. During the first 6-12 h, intracellular labeled glycosaminoglycans accumulated in the dominant dystrophic epidermolysis bullosa cells at about twice the rate as that of control fibroblasts. In addition, secretion of sulfated glycosaminoglycans was two-to threefold greater than in control cultures. In contrast, both pulse-chase and cross-correction experiments failed to show any evidence for defective degradation of the material. The biochemical trait is genetically specific for albopapuloid dominant dystrophic epidermolysis bullosa, since fibroblasts from patients with other varieties of epidermolysis bullosa did not accumulate increased glycosaminoglycans. The data suggest that the in vitro abnormality in glycosaminoglycan metabolism could serve as an important marker for this variety of epidermolysis bullosa and be of genetic and prognostic value in the sporadic patient with epidermolysis bullosa. Although the precise relationship of the defect to the disease has not yet been defined, it is possible that excessive tissue accumulation of glycosaminoglycans may alter collagen fibril deposition, thus, impairing the structural integrity of the skin and leading to posttraumatic blisters and erosions that characterize the disease. 
INTRODUCTION
Epidermolysis bullosa (EB)1 refers to a group ofgenetic disorders characterized by severe blistering after minor trauma to the skin (1). At least four major varieties ofthe disease exist-dominant dystrophic EB, dominant EB simplex, recessive dystrophic EB, and recessive EB letalis-and, although they differ from one another in the degree of severity, each is accompanied by profound morbidity as a result of repeated cutaneous blistering throughout life (2) .
Two subvarieties of dominant dystrophic epidermolysis bullosa (DDEB) occur, the albopapuloid variety of Pasini (3) and the hyperplastic variety of Cockayne (4) and Touraine (5) . Each has its onset at birth or in early infancy and can only be differentiated by the occurrence in the albopapuloid variety of small, fleshcolored papules primarily on the trunk near the time of puberty. These lesions, the so-called albopapuloid lesions, appear spontaneously in the absence of antecedent trauma (1) .
The etiology of either form of DDEB is unknown. However, histochemical examination has revealed an increased amount of degraded chondroitin sulfates in the skin of a patient with albopapuloid DDEB (6) . Furthermore, urinary excretion of both native and partially degraded chondroitin sulfate B was also increased in the patient (7), suggesting that albopapuloid DDEB might be a disorder resulting from abnormal catabolism of acid mucopolysaccharide (6) .
If the albopapuloid variety of DDEB were characterized by an abnormality in glycosaminoglycan metabo-lism, it might be expected that the aberration would be manifested in fibroblast cultures. In the present study we have examined glycosaminoglycan metabolism in fibroblast cultures of seven patients with this variety of DDEB to determine (a) whether deranged glycosaminoglycan metabolism characterizes this form of EB, (b) the nature of any such abnormality in glycosaminoglycan metabolism, and (c) whether this biochemical abnormality might be used as a genetic marker to differentiate albopapuloid DDEB from other varieties of the disease.
METHODS
Fibro blast culture.s. DDEB fibroblast cultures were established from a 3-mm skin punch biopsy after obtaining informed consent. All biopsies were taken from the normal-appearing skin of the upper extremities, and not from blistered areas or albopapuloid lesions. Control cultures were initiated from upper extremity skin of healthy volunteers or were purchased from the American Type Culture Collection, Rockville, Md. As a further control, fibroblast cultures were established from patients with other genetically distinct forms of EB, recessive dystrophic EB and dominant EB simplex. All patients were examined by at least one of us (Dr. Bauer) and classified based on clinical, genetic, and histologic findings as described previously (8) . The cell lines employed in this study are detailed in Table I . Cells 200 ,ug of streptomycin/ml at 37°C in an air-CO2 atmosphere (95-5%). The culture medium was altered by substituting MgCl2 for MgSO4 and reducing the NaHCO3 concentration to 1.6 g/liter (9, 10) .
Incorporation of 35SO into glycosaminoglycans. For labeling experiments, confluent cultures were washed three times and incubated in the above medium adjusted to pH 6.8 with nonvolatile buffers, 10 mM piperazine-N,N'-bis(2-ethanesulfonic acid) and 15 mM N,N'-bis(2-hydroxyethyl)-2-aminoethanesulfonic acid, as described by Lie et al. (10) . The cells were labeled with 4-20 x 10" cpm/ml of carrier-free Na235SO4 (New England Nuclear, Boston, Mass.) and at varying intervals, the cells were washed with Hanks' balanced salt solution, trypsinized, harvested by centrifugation, and extracted f'our times with boiling 80% ethanol as described by Fratantoni et al. (9) . The extracted cell residue was dissolved in 10% NaOH for determination of radioactivity and cell protein.
Labeled glycosaminoglycans were determined in the medium after dialysis for 4 h against 0.1 M (NH4)2SO4 and 48 h against running tap water before determining the radioactivity (9).
Degradationt of 35SO=-labeled glycosaminoglycans. Degradation rates for [35SO=]glycosaminoglycans were determined as described by Fratantoni et al. (9) . Briefly, confluent cell cultures were prelabeled by incubation either for 24 or 72 h in the pH 6.8-adjusted medium with Na235SO4. The radioactive medium was then removed, the cells were passed and replated, and then incubated in the same pH-adjusted medium for specified time periods after which intracellular
[35SOf]glycosaminoglycans were determined as described above.
C/hara cteriza tioni of [35SOZ]glycosa in inoglycaius. The molecular weight distribution of extra-and intracellular 35SO=-labeled material was determined using gel filtration (9) . Samples were applied to a 1.6 x 35-cIml columinii of Sephadex G-200, equilibrated with 0.02 M (NH4)2SO4, and then eluted at a flow rate of 10 ml/h. Uptake of 35S =-labeled coinp1u1n(Is. 35SO=-labeled compounds to be used f'or the endocytosis studies were pre- Endocytosis of labeled material was determined by incubating confluent normal and DDEB cells at 37°C for 7 h at pH 6.8 in 2.0 ml of medium containing the 35SO--labeled compounds as described by Kresse et al. (12) . Briefly, after incubating each of the cell types with either control-derived or DDEB-derived labeled material, the medium was removed and the cell layer was quickly washed five times with Hanks' balanced salt solution. The cells were then harvested by trypsinization and centrifugation and washed one additional time after which they were solubilized for determination of radioactivity and protein (12) . Ethanol-soluble degradation products were determined in the culture medium by adding three volumes of ethanol and allowing the medium to stand at 25°C for at least 3 h. After centrifugation, the radioactivity of the supernate was determined (11, 12) . Endocytosis was defined as the sum of the intracellular radioactivity plus the extracellular labeled ethanol-soluble material minus the ethanolsoluble radioactvity of a medium blank (i.e., the same amount of 35SOm-labeled material added to 2 ml of conditioned medium from the same cell lines and incubated at 37°C for 7 h) (11) . Blank values represented 2-4% ofthe total radioactivity added to the cultures. The mean recovery of radioactivity added to the cultures was 91.3% (range, 84-99%).
Other assays. Chemical quantitation of total hexuronic acid was determined by the carbazole method (13) . Cells were lysed by sonication and a sample was removed for protein determination. The remainder of the lysates were hydrolyzed for 4 h at 37°C in a final concentration of 0.15 M NaOH. After neutralization with acetic acid, any insoluble residue was removed by centrifugation and the glycosaminoglycans were precipitated with 1% cetylpyridinium chloride. This precipitate was dissolved in 0.075 M NaCl and assayed. Protein was determined using established methods (14) .
RESULTS
The kinetics of incorporation of 35SO4= into intracellular glycosaminoglycans in three representative albopapuloid DDEB lines is depicted in Fig. 1 . In normal cells, the amount of intracellular 35SO= in glycosaminoglycans increased for 3-4 d after which a steady state was reached. In contrast, in the albopapuloid DDEB cell lines, radioactivity in intracellular glycosaminoglycans continued to incresae for 6-8 d in one line and for up to 11 d, the longest time period examined, in two lines.
Rates of accumulation of intracellular [35SO4-glycosaminoglycans were also examined at early times in culture (Fig. 2) linear for up to 6 d and was approximately threefold increased in two albopapuloid DDEB cell lines (Fig.  3A, WUE 7559; Fig. 3B , WUE 7570) and about twofold greater in the third cell line (Fig. 3B, WUE 7560) . Again, it is noteworthy that cells taken from a patient with a nonalbopapuloid form of DDEB (WUE 761 11) secreted [35SO7-]glycosaminoglycans at a rate equal to the control cultures (Fig. 3A) .
In separate experiments, [35SO4-]glycosaminoglycan accumulation was determined in both the cells and the culture medium at a single time (Table II) . As a group, the DDEB cells displayed approximately a threefold increase in intracellular labeled material (range, 1.4-to 5.4-fold; P < 0.01), whereas there was a twofold increase in total labeled glycosaminoglycans (medium + cells) in these cultures (range, 1.2-to 2.3-fold; P < 0.005).
To characterize the distribution of the 35SO=-labeled material further, an additional experiment was performed in which the 35SO=-labeled compounds were fractionated into intracellular material, cell layer-associated (pericellular) material released by trypsinization, and extracellular material found in the medium. In this experiment, at the end of the labeling period in the control cells, 11 .3% of the labeled material was intra- cellular, 7.9% was found in the cell layer-associated fraction, and 80.8% was in the medium. Similarly, in the albopapuloid DDEB cultures, 10.7% was intracellular, 7.4% was cell layer-associated, and 81.9% was extracellular. The results of the labeling studies were further substantiated by chemical analysis. As shown in Table III , the hexuronic acid content of five albopapuloid DDEB cell lines was compared with that of seven different normal control lines. Although there was variation among the five DDEB lines examined, the mean intracellular uronic acid content was 1.6-fold increased based on cell protein (P < 0.025).
Removal of the labeled glycosaminoglyean occurs not only by secretion but also by degradation. To determine whether the increase in glycosaminoglycans in the albopapuloid DDEB fibroblasts was the result of a decrease in the rate of degradation, the loss of labeled glycosaminoglycans from the intracellular pool was examined. For these studies, a single large culture was (Fig. 4A) . However, the existence of two metabolically distinct pools can be postulated, one in which glycosaminoglycans are degraded normally and the other which putatively contains glycosaminoglycans which are not readily degraded. Such a pool might take several days to accumulate as shown in Fig. 1 . Thus, in a second set of experimental conditions, cells were prelabeled for 72 h, resulting in a two-to threefold increase in labeled material in the DDEB cells at the start of the chase period (Fig. 4B) . Again, no significant differences in the rates of degradation were observed between the control and DDEB cultures.
The 35SO=-labeled compounds lost from the cells during the chase period were quantitatively recovered in the medium. In the control line 22% of the labeled material was secreted into the medium in macromolec- Experiments were also performed to determine if the accumulation defect in DDEB cells could be corrected in vitro as had been described with the single enzyme defect mucopolysaccharidoses (15) . Albopapuloid DDEB and control fibroblasts were mixed in equal numbers and grown to confluence after which the intracellular accumulation of labeled glycosaminoglycans was determined (Fig. 5) . The radioactivity incorporated The possibility that the increased accumulation of sulfated glycosaminoglycans was due to exaggerated sulfate transport was also assessed in the albopapuloid DDEB and control lines. After a brief exposure to Na235SO4, fibroblast cultures were immediately washed, placed on ice, and harvested by scraping. The lysed cells were then counted to determine the radioactivity which had been internalized. No To determine ifthe enhanced accumulation of[35SO4-glycosaminoglycans was due to defective endocytosis from the medium, both control and DDEB cells were incubated with 35SOT-labeled compounds prepared either from control or DDEB cells (12) . The net (mean +SE) endocytosis by control cultures (n = 4) ofcontrolderived 35SO=-labeled compounds was 3,310+411 cpm/7 h per mg protein (1.3±0.2% of the added radioactivity) compared to 3,307±688 cpm/7 h per mg protein (1.0+0.2% ofthe added radioactivity) in the DDEB cell lines (n = 5; P = NS). Similarly, using labeled material prepared in DDEB cultures, the net uptake by the control cells (n = 4) was 5,430+830 cpm/7 h per mg protein (2.3±0.5% of the added radioactivity) compared to an uptake in the DDEB cultures (n = 5) of 5,845+ 1,461 cpm/7 h per mg protein (1.9±0.5% of the added radioactivity) (P = NS). Thus, differences in the uptake between control and DDEB cultures did not account for greater accumulation ofglycosaminoglycans.
The molecular weight characteristics of intra-and extracellular 35SO=7-labeled compounds were determined by gel filtration (Fig. 6) . The elution patterns of extracellular material from a control (Fig. 6A) and two different albopapuloid DDEB cell lines (Fig. 6B, C) were essentially identical. The two DDEB cell lines displayed a higher proportion of intracellular material eluting between the exclusion volume of the column (Fig. 7) . After a 48-h labeling period, the seven albopapuloid DDEB fibroblast lines had greater than a twofold increase in labeled material compared to control cultures (P < 0.001). In contrast, cell lines initiated from patients with dominant EB simplex and recessive dystrophic EB had values which were 95 and 98% of the control cultures, respectively. Furthermore, it is noteworthy that cells from three patients from two kindreds with another form of DDEB, not of the albopapuloid variety, did not manifest increased accumulation of labeled glycosaminoglycans.
DISCUSSION
The present study demonstrates that fibroblasts taken from patients with the albopapuloid variety of DDEB manifest a defect in glycosaminoglyean metabolism in vitro. This aberration is characterized by an increased accumulation of sulfated glycosaminoglycans both as intra-and extracellular material. The elevation could result either from increased synthesis or decreased deg- (Fig. 2) . (b) Secretion of[35SO-`]glycosaminoglycans into the medium occurred at a significantly greater rate than in control lines (Fig. 3, Table II ). (c) The turnover of labeled glycosaminoglycans in the intracellular pool of the DDEB cells was equal to that of control cells irrespective of whether the DDEB cultures were prelabeled to the same extent (Fig. 4A) or were allowed to accumulate two-to threefold greater 4 thus, enlarging the labeled degradative pool (Fig. 4B) (Figs.  2, 3, and 7 ). More importantly, even the cells from patients with a different subvariety of DDEB did not manifest the abnormality, indicating that the characteristic is genetically unique for albopapuloid DDEB. It is important to stress that the present studies were performed using cells taken only from normal-appearing skin. In no case were the biopsies taken from blistered areas or from the albopapuloid lesions in the patients with DDEB. Thus, the aberration in glycosaminoglycan metabolism is not due to inadvertent cellular selection and is almost assuredly a genetically determined characteristic.
Since the phenotypic characteristics of the dominant and recessive forms of dystrophic EB may be quite similar early in life (1, 2), a specific biochemical marker could be of important prognostic value in the sporadic patient with EB. The apparent specificity ofthis in vitro trait suggests that it might be a useful diagnostic aid in dominant dystrophic EB. In this regard, we have ex-amined fibroblasts from a 1-yr-old sporadic patient whose disease clinically suggests that she may represent a new mutant for DDEB, although she is still too young to have developed albopapuloid lesions. After 48 h in culture, the mean intracellular labeled glycosaminoglycan content in five experiments was 200.3+±29.0% ofcontrol (mean±SE; P < 0.001), indicating that the patient may, indeed, have DDEB of the albopapuloid variety.
In the broader sense, the present studies emphasize the biochemical heterogeneity underlying the various forms of EB. Although an etiology has not been defined for any of the types of EB, fibroblast cultures have been useful in elucidating certain, apparently specific, genetic characteristics. In the case of recessive dystrophic EB, in at least three patients, cultured fibroblasts have been shown to synthesize increased amounts ofan altered form of collagenase (16) , and the data indicate that this finding is unique for recessive dystrophic EB (17) . Similarly, in the present study the increased synthesis of glycosaminoglycans was found only in cells from patients with albopapuloid DDEB. It is, thus, conceivable that these biochemical markers might now be utilized for further genetic studies and for antenatal diagnosis in kindreds at risk.
The relationship of the abnormality in glycosaminoglycan metabolism to the blistering phenomenon is, as yet, unknown. As suggested by McKusick (18) , however, in dominant diseases (such as DDEB), an alteration in the synthesis of a critical structural macromolecule might well be expected to be expressed as an abnormal phenotype. In this regard, there is considerable evidence to indicate that glycosaminoglycans interact with collagen to influence both the rate and quality of collagen fibril formation (19) . Indeed, whereas some mucopolysaccharides promote fibril formation (20, 21) , others hinder it (22) . It may be that accumulation ofglycosaminoglycans, which interact with collagen to lead to aberrant fibril formation, impairs the structural integrity of the skin and causes the posttraumatic blisters and erosions characteristic of albopapuloid DDEB.
